What Do We Know about the Serotonergic Genetic Heterogeneity in Attention-Deficit/Hyperactivity and Autistic Disorders?
The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Shared candidate gene regions point to a link between autistic disorders and attention-deficit/hyperactivity disorder (ADHD). Although they represent nosologically different diagnoses, the disorders do show some shared symptoms, above all inattention. For both disorders, the association with the serotonergic system is a focus of current research. SAMPLING AND METHODS: The current work provides an overview of serotonergic mechanisms in ADHD and autistic disorders as well as the resulting pharmacogenetic approaches. RESULTS: No uniform picture emerges either for ADHD or for autistic disorders. In pharmacogenetic terms, there are some isolated studies on associations between serotonergic mechanisms and pharmacotherapy. For the area of autism, such studies are still lacking. CONCLUSIONS: The presented serotonergic mechanisms show relationships of this polymorphism to ADHD and autistic disorders, but they do not result in a uniform picture. The overlaps can best be explained by a dimensional classification approach. As yet, only a small number of studies on attentional disorders in autism and ADHD using shared samples have been carried out. With regard to diagnostics and therapy, analyses on the etiology of the attentional disorder of ADHD and autism are required.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interest in the co-occurrence of ADHD and ASD has grown tremendously in the last decade, with multiple published studies addressing questions of heritability and shared etiology [13,15,124], as well as common phenotypic and endophenotypic features [17,42].”
From Treatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder (2012) · cites this paper as [124]
Citations
Cites
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162 · cited 1×
“In an experiment on anxiety disorders, in 1996, Lesch et al. [”
MethodHyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476 · cited 1×
“For instance, knock-out mice without a gene for the encoding of the plasma membrane dopamine transporter (DAT) show hyperactivity, which has proved to be consistent with an increased extracellular dopamine concentration [”
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221 · cited 1×
“described for the first time a new type of 44-bp insertion/deletion in the promotor region of the serotonin transporter, which is represented in long (L) and short (S) alleles. The S form leads to a limited transcription and a reduced amount of the transporter. The L form is associated with a quicker uptake of 5-HTT p…”
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.564 · Cited by 1,738
Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity
Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885
Greenberg, B. D., Tolliver, T. J., Huang, S.-J., Li, Q., Bengel, D., & Murphy, D. L. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990205)88:1<83::aid-ajmg15>3.0.co;2-0 · Cited by 533 · cited 1×
“The L/L and the L/S variants show, in comparison to the S form, higher amounts on 5-HTT platelets [”
Kelsey, D. K., Sumner, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., Sutton, V. K., Gonzales, J., Malcolm, S. K., Schuh, K. J., et al. (2004) · Pediatrics · doi:10.1542/peds.114.1.e1 · Cited by 464 · cited 1×
“It is still not clear whether or not there is a real effect on ADHD psychopathology. Noradrenergic substances (atomoxetine) have also proved to be effective in the treatment of ADHD [”
Serotonin Transporter: Gene, Genetic Disorders, and Pharmacogenetics
Murphy, D. L. (2004) · Molecular Interventions · doi:10.1124/mi.4.2.8 · Cited by 448 · cited 1×
“or by other authors also as ‘serotonin transporter promoter region’ (5-HTTLPR) [”
Evidence of linkage between the serotonin transporter and autistic disorder
Jr, E. C., Courchesne, R., Lord, C., Cox, N. J., Yan, S., Lincoln, A., Haas, R., Courchesne, E., & Leventhal, B. L. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000266 · Cited by 425
Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman, S., & Iyengar, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300627 · Cited by 408
Sutcliffe, J. S., Delahanty, R. J., Prasad, H. C., McCauley, J. L., Han, Q., Jiang, L., Li, C., Folstein, S. E., & Blakely, R. D. (2005) · The American Journal of Human Genetics · doi:10.1086/432648 · Cited by 392 · cited 1×
“have suggested various relations that have not been further exploited in this regard. This could be promising in the systematic enquiry of different combinations of polymorphisms as the concern is surely with polygenetic inheritances. It would also take into account a suggestion by Sutcliffe et al. [”
BackgroundMacKenzie, A., & Quinn, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15251 · Cited by 374 · cited 1×
“and the 3′UTR SNP possibly has a negative influence on the stability of the mRNA and the facilitated uptake into the cytoplasm [”
BackgroundAn autosomal genomic screen for autism
Autism, C. L. S. O. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19991215)88:6<609::aid-ajmg7>3.0.co;2-l · Cited by 367
Handen, B. L., Johnson, C. R., & Lubetsky, M. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005548619694 · Cited by 326
Whole blood serotonin in autistic and normal subjects
Anderson, G. M., Freedman, D. X., Cohen, D. J., Volkmar, F. R., Hoder, E. L., McPhedran, P., Minderaa, R. B., Hansen, C. R., & Young, J. G. (1987) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1987.tb00677.x · Cited by 313 · cited 1×
“examined in 153 male Caucasians the association of the 5-HTTLPR with violent behavior and found a significant excess of the short (s) allele and the S/S genotype in patients characterized by recurrent and overt physical aggressive behavior as well as with a history of childhood ADHD. Autistic Disorders The role of the…”
An autosomal genomic screen for autism
(1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19991215)88:6<609::aid-ajmg7>3.3.co;2-c · Cited by 299
A Genomewide Scan for Loci Involved in Attention-Deficit/Hyperactivity Disorder
Fisher, S. E., Francks, C., McCracken, J. T., McGough, J. J., Marlow, A. J., MacPhie, I. L., Newbury, D. F., Crawford, L. R., Palmer, C. G. S., Woodward, J. A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/340112 · Cited by 292
Pharmacogenetics and the serotonin system: initial studies and future directions
Veenstra-VanderWeele, J., Anderson, G. M., & Cook, E. H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00814-1 · Cited by 289 · cited 1×
“found in children and adolescents that exhibited both the 7-repeat allele on the DRD4 receptor and homozygotie for the long allele of the SERT (DRD4*7/5-HTT LL) a less satisfactory improvement of symptoms under treatment with MPH. Veenstra-VanderWeele et al. [”
ASPERGER SYNDROME IN 23 SWEDISH CHILDREN
Gillberg, C. (1989) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1989.tb04031.x · Cited by 284 · cited 1×
“Conversely, inattention or hyperactivity also emerges in certain child and adolescent psychiatric disorders. In a study by Gillberg [”
Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype
Ozaki, N., Goldman, D., Kaye, W. H., Plotnicov, K., Greenberg, B. D., Lappalainen, J., Rudnick, G., & Murphy, D. L. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001365 · Cited by 275
Serotonin transporter (5-HTT) gene variants associated with autism?
Klauck, S. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.13.2233 · Cited by 261
Bakker, S. C., Meulen, E. M. V. D., Buitelaar, J. K., Sandkuijl, L. A., Pauls, D. L., Monsuur, A. J., Slot, R. V. ‘., Minderaa, R. B., Gunning, W. B., Pearson, P. L., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375143 · Cited by 257 · cited 1×
“supports the hypothesis that 19p13 and 17q11.2 are probable candidate genes for autistic disorders. A Dutch study by Bakker et al. [”
BackgroundSmalley, S. L., Kustanovich, V., Minassian, S. L., Stone, J. L., Ogdie, M. N., McGough, J. J., McCracken, J. T., MacPhie, I. L., Francks, C., Fisher, S. E., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342732 · Cited by 240
ADHD symptom subtypes in children with pervasive developmental disorder
Gadow, K. D., DeVincent, C. J., & Pomeroy, J. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-005-0060-3 · Cited by 233 · cited 1×
“described that 74p of children with the DSM-IV diagnosis ‘Pervasive Developmental Disorder Not Otherwise Classified’ (PDD) had previously only been diagnosed as ADHD. A recent study of ADHD subtypes in children with PDD by Gadow et al. [”
Autistic symptoms in children with attention deficit-hyperactivity disorder
Clark, T., Feehan, C., Tinline, C., & Vostanis, P. (1999) · European Child & Adolescent Psychiatry · doi:10.1007/s007870050083 · Cited by 227 · cited 1×
“provides tentative support for an ADHD syndrome in those children. In this context, Clark et al. [”
Support for association between ADHD and two candidate genes: NET1 and DRD1
Bobb, A. J., Addington, A. M., Sidransky, E., Gornick, M. C., Lerch, J. P., Greenstein, D. K., Clasen, L. S., Sharp, W. S., Inoff‐Germain, G., Wavrant‐De Vrièze, F., et al. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30142 · Cited by 223
Ogdie, M. N., Macphie, I. L., Minassian, S. L., Yang, M., Fisher, S. E., Francks, C., Cantor, R. M., McCracken, J. T., McGough, J. J., Nelson, S. F., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375139 · Cited by 220 · cited 1×
“describe the 12-cM and the 7-Mb region of the 16p13 chromosome as a possible variation that can lead to a shared pathology in PDD and ADHD. Furthermore, in a wider study, which comprised a sample of 270 affected sibling pairs, maximum lod scores were found for the regions 17p11, 5p13, 6q14, 11q25, and 20q13 [”
BackgroundRetz, W., Retz‐Junginger, P., Supprian, T., Thome, J., & Rösler, M. (2004) · Behavioral Sciences & the Law · doi:10.1002/bsl.589 · Cited by 219 · cited 1×
“attempted to replicate the occurrence of the 5-HTTLPR, the VNTR and the 3′UTR SNP and an additional 10 SNPs in the using of a quantitative trait locus (QTL) approach. The study also found a significant accumulation of the L form of the 5-HTTLPR in the ADHD group. However, neither a significant association for the VNTR…”
MCDOUGLE, C. J., HOLMES, J. P., BRONSON, M. R., ANDERSON, G. M., VOLKMAR, F. R., PRICE, L. H., & COHEN, D. J. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199705000-00020 · Cited by 211 · cited 1×
“provide an overview in this regard. Investigations into the improvement of attentiveness in children and adolescents with autistic disorders under noradrenergic substances are yet to be undertaken.Additionally, studies of risperidone in adults and children with autism have also reported significant reductions in repet…”
Puumala, T., & Sirviö, J. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00392-8 · Cited by 202
Manor, I., Eisenberg, J., Tyano, S., Sever, Y., Cohen, H., Ebstein, R. P., & Kotler, M. (2001) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20010108)105:1<91::aid-ajmg1069>3.0.co;2-v · Cited by 198
Yoshida, Y., & Uchiyama, T. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-0391-1 · Cited by 195 · cited 1×
“call for an examination for symptoms of a pervasive developmental disorder in all children who are given the diagnosis of ADHD, whereas Yoshida and Uchiyama [”
BackgroundSerotonin alterations in anorexia and bulimia nervosa: New insights from imaging studies
KAYE, W., FRANK, G., BAILER, U., HENRY, S., MELTZER, C., PRICE, J., MATHIS, C., & WAGNER, A. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.04.013 · Cited by 181
Maestrini, E., Lai, C. S. L., Marlow, A. J., Matthews, N., Wallace, S., Bailey, A. J., Cook, E. H., Weeks, D. E., & Monaco, A. P. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19991015)88:5<492::aid-ajmg11>3.0.co;2-x · Cited by 181 · cited 1×
“Several family-based studies showed no association for the serotonin transporter [”
BackgroundNewcorn, J. H., Spencer, T. J., Biederman, J., Milton, D. R., & Michelson, D. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200503000-00008 · Cited by 174
Medication Patterns in Patients with Autism: Temporal, Regional, and Demographic Influences
Aman, M. G., Lam, K. S. L., & Van Bourgondien, M. E. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.116 · Cited by 174 · cited 1×
“In regard to autistic disorders, there are only a small number of studies on medications using larger samples [”
McCauley, J. L., Li, C., Jiang, L., Olson, L. M., Crockett, G., Gainer, K., Folstein, S. E., Haines, J. L., & Sutcliffe, J. S. (2005) · BMC Medical Genetics · doi:10.1186/1471-2350-6-1 · Cited by 168 · cited 1×
“In summary, the study describes the regions 16p1 and 17p11 as well as 5p13 as mutual risk gene regions for ADHD and autistic disorders. A current investigation by McCauley et al. [”
BackgroundKim, S.-J., Cox, N. J., Yeung-Courchesne, R., Lord, C., Corsello, C. M., Akshoomoff, N., Guter, S. J., LEVENTHAL, B. L., Courchesne, E., & Cook, E. H. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001033 · Cited by 165 · cited 1×
“examined the 5-HTTLPR, the VNTR and a haplotype of both gene loci in 52 trios and 65 trios, respectively applying a TDT. In contrast to the American study, the research team found an increased frequency of the long allele of the 5-HTTLPR for the patient group extended from the phenotype (p = 0.032). However, in both s…”
ResultInfluentialMartin, E. R., Menold, M. M., Wolpert, C. M., Bass, M. P., Donnelly, S. L., Ravan, S. A., Zimmerman, A., Gilbert, J. R., Vance, J. M., Maddox, L. O., et al. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(20000207)96:1<43::aid-ajmg9>3.0.co;2-3 · Cited by 161
Hanna, G. L., Himle, J. A., Curtis, G. C., Koram, D. Q., Veenstra-VanderWeele, J., Leventhal, B. L., & Cook, E. H. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00097-3 · Cited by 160 · cited 1×
“Two further important variations of the polymorphism are known: VNTR (variable number tandem repeat) in intron 2 and 3′UTR SNP (untranslated region G/T single nucleotide polymorphism). The VNTR influences the transcription of the transporter [”
BackgroundTreatment of ADHD with Fluoxetine: A Preliminary Trial
Barrickman, L., Noyes, R., Kuperman, S., Schumacher, E., & Verda, M. (1991) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/s0890-8567(10)80011-5 · Cited by 158 · cited 1×
“reported a modest association between autism (specifically between repetitive behavior) and an only recently described brain-expressed tryptophan hydroxylase gene (TPH2). Pharmacogenetics of Serotonergic Active Agents in Hyperkinetic and Autistic Disorders Selective SSRIs are, in addition to psychostimulants such as M…”
Franz, A. R., Bauer, K., Schalk, A., Garland, S. M., Bowman, E. D., Rex, K., Nyholm, C., Norman, M., Bougatef, A., Kron, M., et al. (2004) · Pediatrics · doi:10.1542/peds.114.1.1 · Cited by 156
Kent, L., Doerry, U., Hardy, E., Parmar, R., Gingell, K., Hawi, Z., Kirley, A., Lowe, N., Fitzgerald, M., Gill, M., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001100 · Cited by 153
Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder
Betancur, C., Corbex, M. A., Spielewoy, C., Philippe, A., Laplanche, J., Launay, J., Gillberg, C., Mouren-Siméoni, M., Hamon, M., Giros, B., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj/mp/4000923 · Cited by 151
Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder
Comings, D. E., Gade‐Andavolu, R., Gonzalez, N., Wu, S., Muhleman, D., Blake, H., Chiu, F., Wang, E., Farwell, K., Darakjy, S., et al. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.580106.x · Cited by 151
An Open Trial of Risperidone in Young Autistic Children
Nicolson, R., Awad, G. A., & Sloman, L. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199804000-00014 · Cited by 143
Seeger, G., Schloss, P. D., & Schmidt, M. H. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000820 · Cited by 142
Coutinho, A. M., Oliveira, G. G., Morgadinho, T., Fesel, C., Macedo, T. R. A., Bento, C., Marques, C., Ataíde, A., Miguel, T., Borges, L., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001409 · Cited by 141
McCauley, J. L., Olson, L. M., Dowd, M., Amin, T., Steele, A., Blakely, R. D., Folstein, S. E., Haines, J. L., & Sutcliffe, J. S. (2004) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20151 · Cited by 136
Anderson, G. M., Gutknecht, L., Cohen, D. J., Brailly‐Tabard, S., Cohen, J. H. M., Ferrari, P., Roubertoux, P. L., & Tordjman, S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001099 · Cited by 135 · cited 1×
“report a positive association between increased serotonin blood levels and haplotypes of the 5-HTTLPR and intron 2 polymorphisms. Three further studies found similar non-significant tendencies regarding the link between homozygote forms of the homozygote L form of the transporter and increased serotonin blood levels [”
Hattori, J., Ogino, T., Abiru, K., Nakano, K., Oka, M., & Ohtsuka, Y. (2006) · Brain and Development · doi:10.1016/j.braindev.2005.11.009 · Cited by 124
Persico, A. M., Militerni, R., Bravaccio, C., Schneider, C., Melmed, R., Conciatori, M., Damiani, V., Baldi, A., & Keller, F. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(20000207)96:1<123::aid-ajmg24>3.0.co;2-n · Cited by 124
Elevated blood serotonin in autistic probands and their first-degree relatives
Abramson, R. K., Wright, H. H., Carpenter, R., Brennan, W., Lumpuy, O., Cole, E., & Young, S. R. (1989) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02212938 · Cited by 123
Hamarman, S., Fossella, J., Ulger, C., Brimacombe, M., & Dermody, J. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2004.14.564 · Cited by 118
Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population
Conroy, J., Meally, E., Kearney, G., Fitzgerald, M., Gill, M., & Gallagher, L. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001459 · Cited by 117
CASE STUDY Methylphenidate Treatment of Hyperactive Autistic Children
Birmaher, B. B., Quintana, H., & Greenhill, L. L. (1988) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198803000-00020 · Cited by 111
The cognitive profile of anorexia nervosa: A comparative study including a community-based sample
Gillberg, I. C., Gillberg, C., Råstam, M., & Johansson, M. (1996) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(96)90046-2 · Cited by 108 · cited 1×
“mentioned in the introduction, underlines the importance of serotonergic mechanisms in terms of ADHD as the analyses of the authors suggested that in hyperactivity in the animal model, the effect of psychostimulants is dependent on serotonergic neurotransmission.Nevertheless, serotonergic mechanisms, especially the 5-…”
Childhood psychosis and neurofibromatosis—more than a coincidence?
Gillberg, C., & Forsell, C. (1984) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02408551 · Cited by 108
Blood platelet uptake of serotonin in episodic aggression
Brown, C. S., Kent, T. A., Bryant, S. G., Gevedon, R. M., Campbell, J. L., Felthous, A. R., Barratt, E. S., & Rose, R. M. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90003-6 · Cited by 105 · cited 1×
“DiscussionThe 5-HTTLPR is described in relation to a series of personality traits such as anxiety, depressiveness, obsessive-compulsivity, impulsivity and aggressiveness, which can belong to the spectrum of symptoms of different psychiatric disorders. For instance, Brown et al. [”
Spivak, B., Vered, Y., Yoran‐Hegesh, R., Averbuch, E., Mester, R., Graf, E., & Weizman, A. (1999) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1999.tb07229.x · Cited by 100
Zoroğlu, S. S., Erdal, M. E., Alaşehirli, B., Erdal, N., Sivasli, E., Tutkun, H., Savaş, H. A., & Herken, H. (2002) · Neuropsychobiology · doi:10.1159/000063667 · Cited by 99 · cited 1×
“replicated this result and examined in a sample of 113 trios in addition further polymorphisms of the transporter, VNTR and 3′UTR SNP. The odds ratio for alleles in this study lay at 1.29 (in comparison to works by Manor et al. (1.23) and by Seeger et al. (1.46)). Particularly noteworthy was the fact that in a pooled…”
ResultInfluentialRoman, T., Schmitz, M., Polanczyk, G. V., Eizirik, M., Rohde, L. A., & Hutz, M. H. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20018 · Cited by 98
Comings, D. E., Gade‐Andavolu, R., Gonzalez, N., Blake, H., Wu, S., & MacMurray, J. P. (1999) · Clinical Genetics · doi:10.1034/j.1399-0004.1999.550304.x · Cited by 96 · cited 1×
“examined with the support of the Multivariate Analysis of Associations (MAA) Technique 42 candidate regions for ADHD and conduct disorders. According to their results, noradrenergic genes play the greatest role in ADHD. Recently, the active agent atomoxetine, which targets the noradrenergic transmitter system, has bee…”
MethodBattersby, S., Ogilvie, A. D., Blackwood, D. H. R., Shen, S., Muqit, M. M. K., Muir, W. J., Teague, P., Goodwin, G. M., & Harmar, A. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721384.x · Cited by 93
Coon, H., Dunn, D., Lainhart, J., Miller, J., Hamil, C., Battaglia, A., Tancredi, R., Leppert, M. F., Weiss, R., & McMahon, W. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30168 · Cited by 90
The serotonin transporter gene as a QTL for ADHD
Curran, S., Purcell, S., Craig, I., Asherson, P., & Sham, P. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30118 · Cited by 86 · cited 1×
“however, found no evidence of association between either the 5-HTTLPR or the VNTR in ADHD using an extended transmission disequilibrium test (TDT). They argued that this might be due to a lack of statistical power, but also suggest that the 5-HTTLPR and the VNTR are not the relevant polymorphisms.Also in 2005, a study…”
Randomized Trial of Methylphenidate for an Autistic Child
Strayhorn, J. M., Rapp, N. L., Donina, W. M., & Strain, P. S. (1988) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198803000-00019 · Cited by 85
Salmon, B., Hallmayer, J., Rogers, T., Kalaydjieva, L., Petersen, P. B., Nicholas, P., Pingree, C., McMahon, W., Spiker, D., Lotspeich, L., et al. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19991015)88:5<551::aid-ajmg21>3.0.co;2-# · Cited by 85
Jensen, V. K., Larrieu, J. A., & Mack, K. K. (1997) · Clinical Pediatrics · doi:10.1177/000992289703601001 · Cited by 83 · cited 1×
“21p of the children and adolescents fulfilled both the diagnostic criteria for ADHD and for an Asperger syndrome, and in 36p autistic traits were apparent. With an average prevalence rate of 4p in Continental European studies, this results in an overlap population of 0.8 or 1.4p in non-selected samples. Jensen and Mac…”
InfluentialSpence, S. J. (2004) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2004.07.003 · Cited by 82
Di Martino, A., Melis, G., Cianchetti, C., & Zuddas, A. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/1044546041649011 · Cited by 82
An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder.
Hedges, D., Reimherr, F. W., Rogers, A., Strong, R. E., & Wender, P. H. (1995) · PubMed · Cited by 81
The norepinephrine transporter gene and attention‐deficit hyperactivity disorder
Barr, C. L., Kroft, J., Feng, Y., Wigg, K., Roberts, W., Malone, M., Ickowicz, A., Schachar, R., Tannock, R., & Kennedy, J. L. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10193 · Cited by 79
Seeger, G., Schloss, P. D., & Schmidt, M. H. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02253-4 · Cited by 78
Rohde, L. A., Roman, T., Szobot, C., Cunha, R. D., Hutz, M. H., & Biederman, J. (2003) · Synapse · doi:10.1002/syn.10186 · Cited by 75 · cited 1×
“provide an overview of ADHD and pharmacogenetics. For instance, in one study, investigating links between DAT-1, response to MPH and cerebral blood flow in children and adolescents with ADHD, an increased regional blood flow mediofrontal and in the area of the left basal ganglia for DAT-1 homozygote affected patients…”
Halperin, J. M., Newcorn, J. H., KOPSTEIN, I., McKay, K. E., Schwartz, S. T., Siever, L. J., & Sharma, V. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199710000-00021 · Cited by 74
Open-label trial of venlafaxine in adults with attention deficit disorder.
Adler, L. A., Resnick, S., Kunz, M., & Devinsky, O. (1995) · PubMed · Cited by 72
Attention deficit hyperactivity disorder and whole-blood serotonin levels: effects of comorbidity
Cook, E. H., Stein, M. A., Ellison, T., Unis, A. S., & LEVENTHAL, B. L. (1995) · Psychiatry Research · doi:10.1016/0165-1781(95)02596-o · Cited by 69 · cited 1×
“describe a significant negative correlation between the uptake of serotonin in platelets and impulsivity scores in adult males. In children and adolescents with increased aggressiveness, links can be found with increased peripheral serotonin blood level [”
BackgroundRuotsalainen, S., Sirviö, J., Jäkälä, P., Puumala, T., MacDonald, E., & Riekkinen, P. J. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00389-6 · Cited by 62 · cited 1×
“In contrast, the serotonergic and noradrenergic mechanisms are poorly researched.Animal studies indicate that dopamine and serotonin in the frontal cortex play a role with regard to the modulation of attention and ‘response control’ [”
BackgroundLangley, K., Payton, A., Hamshere, M. L., Pay, H., Lawson, D. C., Turic, D., Ollier, W., Worthington, J., Owen, M. J., O’Donovan, M. C., et al. (2003) · Psychiatric Genetics · doi:10.1097/01.ypg.0000056177.32550.a5 · Cited by 59
Persico, A. M., Pascucci, T., Puglisi-Allegra, S., Militerni, R., Bravaccio, C., Schneider, C., Melmed, R., Trillo, S., Montecchi, F., Palermo, M., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001069 · Cited by 56
Treating Functional Impairment of Autism with Selective Serotonin-Reuptake Inhibitors
Moore, M. L., Eichner, S. F., & Jones, J. R. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d543 · Cited by 53
Serotonin transporter regulatory region polymorphism is associated with anorexia nervosa
Matsushita, S., Suzuki, K., Murayama, M., Nishiguchi, N., Hishimoto, A., Takeda, A., Shirakawa, O., & Higuchi, S. (2004) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30022 · Cited by 50 · cited 1×
“might be a further evidence for the necessity of a dimensional approach and can probably also be explained through serotonergic mechanisms [”
Increased Density of the Platelet Serotonin Transporter in Autism
Marazziti, D., Muratori, F., Cesari, A., Masala, I., Baroni, S., Giannaccini, G., Dell'Osso, L., Cosenza, A., Pfanner, P., & Cassano, G. B. (2000) · Pharmacopsychiatry · doi:10.1055/s-2000-7588 · Cited by 47 · cited 1×
“that appears to be due to enhanced 5-HT transport into platelets and decreased 5-HT 2 receptor binding [”
BackgroundFayet, G., Couraud, F., Miranda, F., & Lissitzky, S. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90142-3 · Cited by 42
Pharmacologic Treatment of Autism
Palermo, M. T., & Curatolo, P. (2004) · Journal of Child Neurology · doi:10.1177/088307380401900301.155 · Cited by 39
Luca, V. D., Muglia, P., Jain, U., & Kennedy, J. L. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20075 · Cited by 39
ADHD, Asperger syndrome, and high-functioning Autism
Holtmann, M., Bölte, S., & Poustka, F. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000177322.57931.2a · Cited by 32
Adrenergic alpha 2C receptor genomic organization: Association study in adult ADHD
De Luca, V., Muglia, P., Vincent, J. B., Lanktree, M., Jain, U., & Kennedy, J. L. (2004) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20171 · Cited by 26
Attention deficit hyperactivity disorder: unravelling the molecular genetics
Thapar, A. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000452 · Cited by 19 · cited 1×
“The dopaminergic neurotransmitter system appears to be important in terms of the etiology and the treatment of ADHD [”
Attention-deficit/hyperactivity disorder: current aspects on pharmacogenetics
Rohde, L. A., Roman, T., & Hutz, M. H. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500158 · Cited by 13
Donovan, A., Halperin, J. M., Newcorn, J. H., & Sharma, V. (1999) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1999.9.85 · Cited by 9
Research works printed but not linked: 2
- 10.1097%2F00041444-200306000-00009 · doi:10.1097/00041444-200306000-00009
- 10.1097%2F00004583-199109000-00010 · DOI
Cited by
Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder
Rommelse, N. N. J., Franke, B., Geurts, H. M., Hartman, C. A., & Buitelaar, J. K. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0092-x · Cited by 564
“Accordingly, genes related to these pathways have been the prime candidates for molecular investigation in both disorders [5, 87; see also elsewhere in this issue].”
InfluentialTreatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder
Davis, N. O., & Kollins, S. H. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0126-9 · Cited by 156
The comorbidity of ADHD and autism spectrum disorder
Antshel, K. M., Zhang-James, Y., & Faraone, S. V. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.840417 · Cited by 147
Chantiluke, K., Barrett, N., Giampietro, V., Santosh, P., Brammer, M., Simmons, A., Murphy, D. G., & Rubia, K. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3837-2 · Cited by 63
“Thus, polymorphisms of serotonergic genes have been associated with both ADHD and ASD (Rommelse et al. 2010; Sinzig and Lehmkuhl 2007).”
BackgroundChantiluke, K., Barrett, N., Giampietro, V., Brammer, M., Simmons, A., Murphy, D. G., & Rubia, K. (2015) · Cerebral Cortex · doi:10.1093/cercor/bht365 · Cited by 59
Metadata
- Authors
- Sinzig, J., & Lehmkuhl, G.
- Affiliations
- University of Cologne (DE)
- ORCID
- Sinzig, J.
- Venue
- Psychopathology
- Publisher
- S. Karger AG
- Published
- 2007
- Volume
- 40
- Issue
- 5
- Pages
- 329-337
- ISSN
- 0254-4962 (ISSN-L)
- 1423-033X
- OpenAlex
- W2026949173
- Cited by
- 14
- References
- 91
- Citations by year
- 2018: 1 · 2017: 1 · 2015: 1 · 2014: 2 · 2013: 2 · 2012: 3
- FWCI
- 0.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychopathology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- attention deficit hyperactivity disorder, autism spectrum disorder, serotonergic system, genetic polymorphism, pharmacogenetics, inattention, dimensional classification
- MeSH terms
- Attention Deficit Disorder with Hyperactivity, Autistic Disorder, Child, Chromosomes, Human, Pair 17, Genotype, Humans, Promoter Regions, Genetic, Comorbidity, Selective Serotonin Reuptake Inhibitors, Minisatellite Repeats, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.